HKSE - Delayed Quote HKD

PEIJIA-B (9996.HK)

Compare
4.130 +0.010 (+0.24%)
At close: October 25 at 4:08 PM GMT+8

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.
NameTitlePayExercisedYear Born
Dr. Yi Zhang Chairman & CEO 1.6M -- 1968
Mr. Leo Tsai Chief Financial Officer -- -- 1982
Mr. Kongrong Pan Chief Operating Officer -- -- 1959
Dr. Fong Tan Jian Chief Technology Officer -- -- 1976
Ms. Ping Ye Zhang Executive Director 199.29k -- 1968
Ms. Hong Ye Executive Director & Company Secretary 820.15k -- 1972
Ms. Xiaoxiao Zhuang Vice President of Sales -- -- 1983
Ms. Hongpeng Wang Vice President of Marketing -- -- 1981
Ms. Hing Ling Chau FCIS, FCS, L.L.M. Company Secretary -- -- 1975

PEIJIA-B

8 Zhongtian Street
Suzhou Industrial Park
Suzhou, 215028
China
86 512 8187 7166 https://www.peijiamedical.com
Sector:?
Healthcare
Industry:?
Medical Devices
Full Time Employees:?
1,050

Description

Peijia Medical Limited engages in the research and development of transcatheter valve therapeutic and neuro interventional procedural medical devices. Its transcatheter valve therapeutic products include TaurusOne, a transcatheter aortic valve replacement (TAVR) system; TaurusElite, a retrievable TAVR system; TaurusNXT, a non-glutaraldehyde crosslinking dry-tissue TAVR system; TaurusMax, an iteration steerable TAVR system; TaurusTrio, a TAVR system; TaurusWave, a lithotripsy valvuloplasty system; TaurusApex, a polymeric leaflet TAVR system; Trilogy, a TAVR System; HighLife, a transseptal mitral value replacement system; Sutra Hemi Valve, a TMV coaptation augmentation system; GeminiOne, a transcatheter edge-to-edge repair system; MonarQ which is transcatheter tricuspid valve replacement systems; TaurusAtlas, a transfemoral balloon catheter; TaurusExplora, a pre-shaped guidewire; and TaurusNavi, an introducer sheath. The company also offers Jasper and Presgo, that are detachable coils; Jasper SS detachable coil; intracranial adjunctive stents; SacSpeed, a balloon dilatation catheter; Tethys AS, an aspiration catheter; Syphonet, a stent retriever; Fastunnel, a balloon microcatheter; Fluxcap, a balloon guiding catheter; NeuroStellar, an intracranial stent; Presgo microcatheter and micro guidewire; Heralder guiding catheter and distal access catheter; Tethys, an intermediate catheter; and Jasper power supply. In addition, it engages in the trading business. Peijia Medical Limited was incorporated in 2012 and is headquartered in Suzhou, the People's Republic of China.

Corporate Governance

PEIJIA-B’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

August 23, 2024 at 2:51 PM UTC

PEIJIA-B Earnings Date

Recent Events

Related Tickers